Epifluorescence videomicroscopy permits real-time imaging of platelet adhesiodaggregation t o a defined microinjury of a monolayer of endothelial cells exposed t o flowing blood. The fluorescent label is the TAB murine monoclonal antibody directed against human platelet GP 118, together with a fluorescein-conjugated goat F(ab'), against murine immunoglobulin. The combination assures specificity for platelet membranes, yet leaves platelet function intact. TAB is first added t o gently mixed, citrated human blood; the second antibody is added 1 hour after the first, mixing continuing for a second hour. Bovine aortic endothelial cell monolayers (ECMs), grown on rectangular cover glasses precoated with microfibrillar collagen, comprise one wall of a flow chamber mounted on a vertical microscope stage. A loop of 6-0 sterile suture is drawn across the ECM in order t o create microinjuries of width 70 f 15 pm (mean k SD) oriented in a direction transverse t o flow. Platelet adhesion/ aggregation is virtually absent on intact and confluent regions of the monolayer. On micro-injury sites and at shear rates of 60 t o 1,080 sec-I. however, computer- emission wavelength is 505 nm. In order to minimize possible platelet or endothelial cell injury, an image intensifier has been used so that incident light of low energy may be used. This technique has permitted the observation in tube flow of platelets interacting with gaps between neighboring endothelial cells of an endothelial cell monolayer,' and the monitoring in a parallel-plate flow of platelet deposition on collagencoated glass.4 In the present work we use for first time epifluorescence videomicroscopy of platelet adhesion/aggregation using the TAB monoclonal antibody (MoAb)' to platelet glycoprotein (GP) IIB, to which has been bound fluorescein-conjugated F(ab')2 fragments of a second antibody. This approach is advantageous in that the MoAb is platelet-specific: quinacrine is also taken up by granulocytes and endothelial cells. Further, we apply our method to the study of platelet adhesion/aggregation at an approximately 70-micron wide mechanical injury to an otherwise intact endothelial cell monolayer under conditions of controlled blood flow. In other words, we are concerned with real-time imaging of primary platelet hemostasis under defined rheologic conditions. The method reported here incorporates image intensification, real-time image digitalization and background subtraction, and off-line measurement of the degree of coverage of the injury area by platelet adhesion/aggregation, and mean aggregate thickness. Parallel measurement of outflow levels of thromboxane and prostacyclin is performed by means of specific radioimmunoassays (RIAs).
Epifluorescence videomicroscopy permits real-time imaging of platelet adhesiodaggregation t o a defined microinjury of a monolayer of endothelial cells exposed t o flowing blood. The fluorescent label is the TAB murine monoclonal antibody directed against human platelet GP 118, together with a fluorescein-conjugated goat F(ab'), against murine immunoglobulin. The combination assures specificity for platelet membranes, yet leaves platelet function intact. TAB is first added t o gently mixed, citrated human blood; the second antibody is added 1 hour after the first, mixing continuing for a second hour. Bovine aortic endothelial cell monolayers (ECMs), grown on rectangular cover glasses precoated with microfibrillar collagen, comprise one wall of a flow chamber mounted on a vertical microscope stage. A loop of 6-0 sterile suture is drawn across the ECM in order t o create microinjuries of width 70 f 15 pm (mean k SD) oriented in a direction transverse t o flow. Platelet adhesion/ aggregation is virtually absent on intact and confluent regions of the monolayer. On micro-injury sites and at shear rates of 60 t o 1,080 sec-I. however, computerenhanced images obtained by means of videomicroscopy show arrival and adherence of single platelets resulting in the formation of platelet aggregates elongated in the flow direction. When the monolayers are pretreated with 1 .O mmol/L lysine acetylsalicylate, the mean aggregate thick-INGLE PLATELETS and the structure of small aggre-S gates can be studied in flowing blood by epifluorescence microscopy. '-4 In this approach, platelets have been made fluorescent by addition of 10 Mmol/L quinacrine dihydrochloride to heparinized human blood. The quinacrine, taken up by platelet dense granules, possesses an intrinsic fluorescence when excited with incident light of wavelength 440 nm; emission wavelength is 505 nm. In order to minimize possible platelet or endothelial cell injury, an image intensifier has been used so that incident light of low energy may be used. This technique has permitted the observation in tube flow of platelets interacting with gaps between neighboring endothelial cells of an endothelial cell monolayer,' and the monitoring in a parallel-plate flow of platelet deposition on collagencoated glass.4 N = 6) of control, aggregates are regularly shed downstream, and the surface area of the injury site covered by platelets is augmented (2P< .05) from 14.8 k 3.9% t o 49.2 f. 4.7% (mean f SE, N = 6). Donor ingestion of aspirin, on the other hand, leads t o an increase (2P < .01) in percent surface coverage t o 42.7 ? 8.5 without a concomitant increase in mean aggregate thickness. In parallel with the above, outflow levels of serum thromboxane and prostacyclin are measured by radioimmunoassays (RIAs) for thromboxane 82 and 6-Keto-PGF,,, respectively. In the present work we use for first time epifluorescence videomicroscopy of platelet adhesion/aggregation using the TAB monoclonal antibody (MoAb)' to platelet glycoprotein (GP) IIB, to which has been bound fluorescein-conjugated F(ab')2 fragments of a second antibody. This approach is advantageous in that the MoAb is platelet-specific: quinacrine is also taken up by granulocytes and endothelial cells. Further, we apply our method to the study of platelet adhesion/aggregation at an approximately 70-micron wide mechanical injury to an otherwise intact endothelial cell monolayer under conditions of controlled blood flow. In other words, we are concerned with real-time imaging of primary platelet hemostasis under defined rheologic conditions. The method reported here incorporates image intensification, real-time image digitalization and background subtraction, and off-line measurement of the degree of coverage of the injury area by platelet adhesion/aggregation, and mean aggregate thickness. Parallel measurement of outflow levels of thromboxane and prostacyclin is performed by means of specific radioimmunoassays (RIAs).
METHODS

Blood donors.
Blood was collected by venipuncture (21 -gauge needle) from four healthy adult donors into polypropylene tubes containing a solution of trisodium citrate (one part solution to nine parts blood; 0.38% final concentration of citrate). None of the donors had taken aspirin or any aspirin-like drugs in the preceding 10 days. Just before oral ingestion of one 300 mg aspirin tablet, 40 mL of blood was withdrawn, and another 20 mL was collected 2 hours later.
To each 10 mL of blood was added 5 pL of TAB (see above; 3.5 mg/mL) diluted in 195 pL of phosphatebuffered saline (PBS). The resulting TAB concentration of 1.75
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pg/mL can be expected to yield binding of 70% of the 44,000 binding sites per platelet within 30 minutes.' TAB has only a slight effect in citrated blood on '2'I-fibrinogen binding to platelets or adenosine diphosphate (ADP)-induced aggregation? We have confirmed the latter finding in preliminary experiments using a conventional aggregometer. In addition, although TAB is directed against human platelet GP IIB, it possesses negligible cross-reactivity with endothelial cell GPIIB (by immunoperoxidase procedures; R.P. McEver, personal communication, August 1985) and does not bind to erythrocytes or to lymphocytes.' After the blood has been on a rocker for 1 hour, we add 5 pL of a fluorescein-conjugated goat F(ab'), directed against murine immunoglobulin (1.3 mg/mL; Jackson Immuno Research, Avondale, PA) and diluted in 195 pL of PBS. This concentration was found empirically to be the lowest concentration yielding near-maximal platelet fluorescence. Labeling is complete after the blood has spent an additional hour on the rocker. Control blood has been similarly handled, except that a nonspecific mouse immunoglobulin (Pel-Freez, Rogers, AK) is substituted for TAB. Figure 1 depicts the experimental system. Labeled blood (20 to 50 mL) is placed in a magnetically stirred (60 rpm), 50 mL, siliconized glass beaker maintained at 37OC, by a water bath. Provided the blood volume in the beaker does not fall below 5 mL, there is no detectable formation of stirrer-induced platelet aggregates. The stirring rate used, further, is much lower than the 1,000 rpm that is standard with the Born-O'Brien aggregometer. A withdrawal pump (Model 906, Harvard Apparatus Co, South Natick, MA) draws blood through a 110 cm length of 0.20 cm internal diameter Silastic tubing (Dow Corning, Indianapolis, IN) to the inlet port of a special flow chamber. A counter-current heat exchanger ensures that blood entering the chamber remains at 37OC, as confirmed by a temperature probe (Model TH-5, Bailey Instruments, Inc, Saddlebrook, NJ) positioned in the chamber's inlet header.
The chamber itself, shown in Figs 2A and B, provides for the thin-film, parallel-plate flow of blood past a monolayer of endothelial cells grown to confluence on a rectangular cover glass (see below).
Flow conditions are determined by the film thickness (290 pm) and pump rate. Shear rates at the chamber walls, estimated from the bulk flow, range from 68 to 1,080 sec-1 for volumetric flow rates of 0.25 to 4.0 mL/min. The lucite wall opposite the monolayer is machined so that steps or grooves securely hold rectangular inner and outer gaskets made from 0.790 mm-thick Silastic sheeting (Dow
Flow system.
Corning, Midland, MI). The inner gasket determines the monolayer area (1.9 cm2) exposed to blood, as well as the film thickness, while the horizontal space between the two gaskets is connected to laboratory vacuum. This vacuum allows for rapid assembly or disassembly of the chamber components between experimental runs.
Bovine aortic endothelial cells of passage number less than 24 were grown to confluence on 60 x 22 mm cover glasses (thickness #l; Fisher Scientific, New York, NY) under static conditions as previously described.' Before endothelial seeding, however, we precoated the cover glasses with microfibrillar collagen (collagen reagent Horm; Hormon Chemie Munich, FRG). The collagen was added by airbrush (Model 100-2-IL; Badger Air-Brush Co, Franklin Park, IL) application of 0.25 mL of a 40 pg/mL suspension. The nominal surface concentration of collagen, therefore, was 0.2 pg/cm2. Just before chamber assembly for an experimental run, a loop of 6-0 sterile suture was drawn edgewise across the width of a given monolayer near its longitudinal midpoint.
This step resulted in a very narrow (70 15 pm; mean * SD) band of endothelial cell removal, as shown in Fig 3. Once the chamber was assembled, the flow passage was immediately filled with culture medium in order to keep the monolayers moist and to prevent the subsequent formation of an air-blood interface. Blood flow began within 5 minutes of monolayer injury.
Preliminary experiments indicated that flow-limited (maximal) platelet adhesion/aggregation at an injury site occurred only with monolayers at least 10 days old; none were used beyond 17 days of age. Diminished platelet adhesion/aggregation was consistently seen with monolayers younger than 10 days, suggesting that the generation of sufficient subendothelial matrix is important even in the presence of a precoating with microfibrillar collagen. This observation is certainly consistent with the fact that human platelets (unlike dog or rabbit platelets) do not appreciably adhere to glass* and a variety of artificial surfaces exposed to flowing blood. ' In order to demonstrate in this model the functional importance of products of endothelial cell cyclo-oxygenase, some monolayers were incubated with 1 .O mmol/L final concentration lysine acetylsalicylate (Maggioni Farmaceutici, Milan, Italy) for 30 minutes or more before mechanical injury. This was accomplished by adding to the culture medium one percent by volume of 100 mmol/L lysine acetylsalicylate, a water soluble form of aspirin. A comparable volume of saline was added to control monolayers.
As a further control, we compared the effects of 1 mmol/L lysine acetylsalicylate (LA) and 100 pmol/L acetylsalicylic acid (ASA) in reducing PGI, production by unstimulated monolayers. This was performed with ECMs mounted in a well-stirred, nonflow chamber lo filled with complete medium. The ECMs were preincubated with medium, with medium containing LA (30 or 60 minutes), or with medium containing ASA (30 or 60 minutes). PGI, production, ng/mL, was measured after incubation of 0.5 cm2 of monolayer for 2 minutes with 0.5 mL of fresh medium. The 0.5 m L volume was then immediately collected for RIA for 6-Keto-PGF,, and replaced within 30 seconds by 0.5 mL of fresh medium containing 25 pm Na arachidonate. After another 2 minutes, the 0.5 mL volume was again collected for assay for 6-Keto-PGF,,.
Real-time imaging of platelet adhesion/ aggregation at the defined microinjury site used epifluorescence videomicroscopy. The fluorescent label was, as noted, the TAB murine MoAb directed against human platelet GP IIB, together with a fluorescein-conjugated goat F(ab), against murine immuno- This processing sequence makes possible three important off-line measurements. One is the percent of the injury area covered by platelets, a measure of platelet adhesion/aggregation. This percent is taken to be lOOx the ratio of the number of pixels (electronic picture elements) in an electronic window over the injury area with intensity above a certain threshold to the total number of pixels in the window. The threshold is determined visually to correspond to the borders of adherent platelet aggregates (Figs 4 and 5) . In practice, the ratio is computed using in the denominator approximately 3,000 to 7,500 pixels. A second measurement is mean signal intensity for all pixels in the electronic window with intensity greater than the above threshold. Mean signal intensity as percent of control is taken to be a measure of mean aggregate thickness. A third, dependent parameter is the product of the first and second. a measure of thrombus volume. For monolayers of bovine aortic endothelial cells, examples of the first twoof these measurements are given in Table I .
For each of four donors, 7.5-minute blood flow experiments were performed at five shear rates in the following order: 68,270,540. 135, and 1,080 sec I. This order served to reduce the influence of temporal changes in platelet and/or monolayer function.
For each of three donors, replicate 7.5-minute blood flow experiments were carried out over a 3-hour period with normal blood and normal monolayers, normal blood and monolayers preincubated with
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LA, and blood drawn 2 hours post-aspirin ingestion and normal monolayers. One of each of the replicated experiments always occurred early in the 3-hour period; the other always occurred late. Blood for the entire 7.5 minutes of a given run was collected into a withdrawal syringe prefilled with 280 p L of 0.18 mol/L EDTA and 120 pL of 62.5 mmol/L LA. Samples of platelet-poor plasma from this blood were stored frozen until measured in unextracted plasma for prostacyclin and thromboxane by specific RlAs for 6-Keto-PGF,, (sensitivity 20 pg/mL) and thromboxane B2 (sensitivity, 50 pg/mL), respectively. Details of theseassays are provided elsewhere." Although outflow stirring might seem necessary to avoid underestimation of these arachidonic acid products due to effects of disperOut~7ow measurement of prostacyclin and thromboxane. sion, preliminary studies indicated no difference in outflow values of 6-Keto-PGFl, when a stirring rod driven by a DC motor was introduced into the outflow header. This is likely due to the fact that the present outflow measurements concern not "instantaneous" blood samples, but rather ones collected over several minutes.
RESULTS
Platelet aggregate morphology.
The area of monolayer injury became covered within minutes by a combination of singly adherent platelets and platelet aggregates in the 10 to 40 pm size range (Figs 4 and 5) . Percent platelet coverage and mean aggregate thickness both increased with time ( Fig  6) . The aggregates, moreover, formed in chains aligned with the flow direction, with a lateral spacing (=30 pm) comparable to an endothelial cell diameter. Even over the short (e100 pm) longitudinal span of the injury area, aggregate size appeared to increase somewhat. Little or no adhesion/ aggregation occurred on areas of intact endothelium either upstream or downstream from the injury site.
Control experiments with a nonspecific mouse immunoglobulin in lieu of TAB revealed no visible adhesion or aggregation, eliminating nonspecific uptake of fluorescence by platelets as an additional source of fluorescence signal. Figure 7 shows that both percent platelet coverage and mean aggregate thickness passed through maxima as shear rate increased. The maxima occurred between 270 and 540 sec-' for each of the three experiments shown, variability in values of coverage or thickness being less for shear rates at or below 270 sec-'. For this reason, a shear rate of 270 sec-' was selected for the studies below.
LA and aspirin. (Fig 8) . In addition, aggregate base length (data not shown) increased in four of six experiments. Donor ingestion of aspirin, on the other hand, led to a 2.9-fold augmentation (2P < .01) of percent coverage, a decrease (not statistically significant) in aggreEffect of shear rate. gate thickness in five of six experiments leading to a thickness for all six experiments of 78 16 percent of control, and no significant change in the base lengths of the largest aggregates (Fig 9) . A comparison of Figs 4 and 9 suggests that most of the additional surface coverage is due to a large number of very small ( < l o pm) aggregates, if not singly adherent platelets.
RZAs. Table 1 indicates that treatment of the ECMs with L A augments outflow thromboxane B2 1.8-fold ( 2 P < .Ol), while oral aspirin reduces levels of this prostanoid to 24% of control ( 2 P < .OS). The level of outflow 6-Keto-PGFI, is reduced (2P < .OS) by monolayer pretreatment to a background value characteristic of citrated blood before entering the chamber. This background value represents some combination of 6-Keto-PGF1, derived from leukocytes and plasma prostaglandins with which the antibody used in the RIA for 6-Keto-PGF,, has some cross-reactivity.
LA reduced basal production of PGI, as well as ASA for preincubations of 30 and 60 minutes, respectively ( Table 2 ). After stimulation with 25 pmol/L Na arachidonate, control monolayers showed an increase in production of 6-Keto-PGFI, to 2.729 + 0.717 ng/mL NonfIow studies. (mean f SE, n = 4). For the 14 pretreated monolayers, however, such stimulation yielded no increase greater than 0.007 ng/mL. L A and aspirin, therefore, eliminated greater than 99% of stimulated production of prostacyclin a t the concentrations (1 mmol/L and 100 pmol/L, respectively) used. Residual levels of 6-Keto-PGF,, for unstimulated but pretreated monolayers are associated with the serum component of the complete medium used and, therefore, represent whole blood-derived prostaglandins that either are 6-Keto-PGF,, or cross react with the antibody used in the RIA.
DISCUSSION
Imaging primary hemostasis. In this work, epifluorescence videomicroscopy allows real-time imaging of platelet adhesion/aggregation to a simulated vessel wall injury. The injury model uses an endothelial cell monolayer grown to confluence on a rectangular cover glass and exposed in vitro to controlled blood flow in a chamber. Mechanical removal of a narrow band (~1 0 0 pm) of cells from the monolayer a t the time of chamber assembly gives rise to a local site on which platelets readily adhere and aggregate; neighboring endothelium remains intact. Since the fluorescent label uses the TAB murine MoAb specific to human platelet GPIIB,5*6 only platelets and platelet membranes are seen. This feature permits background subtraction of digitized images (and subsequent digital amplification) in a way impossible with quinacrine. With blood incubated with 10 pmol/L quinacrine, endothelial cells are found to accumulate a significant and steadily increasing amount of this substance in their cytoplasm, yielding an endothelial cell signal that is impossible to subtract away.
Computer enhancement reveals, in fact, the adherence, remodeling and growth of small (10 to 40 pm) platelet aggregates in chains aligned with the flow direction. In agreement with earlier observations in a system using quinacrine as the fluorescent labe1,3-4 the aggregates grow preferentially from their downstream edges. Occasionally aggregate "tails" can be seen to overhang the downstream edge of the injury site. A further observation is that the chains of aggregates have a lateral periodicity or spacing (-30 pm) that corresponds to the average width of an endothelial cell. This spacing is likely to be in part a consequence of lateral variations in longitudinal flow velocity caused by the finite height of the endothelial cell body and nucleus. Such variations in flow velocity have been seen with red cells labeled nonspecifically with sodium fluorescein; the red cells nearest the monolayer move faster in the "valleys" between neighboring endothelial cells.'* The dynamic, often unstable nature of platelet aggregation upon a synthetic' or ~ubendothelial'~ surface exposed to flowing blood underscores the critical importance of in situ, continuous imaging of local platelet surface interactions, as with an approach using epifluorescence videomicroscopy. This is particularly true with respect to detection and quantitation of embolic events and the nature of aggregate growth and restructuring leading up to such events. Morphometric techniq~es'~*'' allow exquisite resolution of details of platelet adhesion/aggregation to subendothelium, but frequently describe only a single end point in time. Radiolabel-ing approaches""* describe events well in real time but are limited to a spatial resolution of several hundred microns. Because of the opacity of blood, further, transmitted light microscopy, even with image enhancement" or internalreflected microscopy," are limited by light scattering to a resolution of 50 to 100 pm.
Platelet adhesion/aggregation at and below 270 sec-' in the present system is limited by the rate of arrival of fresh platelets by convection." At higher rates of shear, one or more of the following factors becomes limiting: shear stresses overcoming forces of platelet-platelet cohesion; dilution of proaggregatory substances, such as thrombin, ADP, and thromboxane; and increased production (with flow) of endothelial cell PGI2. Selection of 270 sec-l as a "standard" shear rate in this work, therefore, serves to maximize sensitivity of the experiments both to endothelial cell function and rate of growth of adherent aggregates.
Role ofshear rare. Modulatory role of endothelium. Pretreatment of the ECM with LA leads to the formation of much greater adhesion/aggregation and a significant increase in thromboxane production. The increase in percent platelet coverage is due directly to increased aggregate base area; very few singly adherent platelets are seen (Fig 8) . There is also an increase in the frequency and extent to which the most distal portions of the adherent aggregates are shed to downstream locations, when one observes events in real time. These data clearly indicate that products of an ECM that are inhibitable by aspirin modulate local adhesion/aggregation; their inhibition, as by vasculitis or drugs. may give rise to thrombotic states. Moreover. these data demonstrate the functional importance for the injury model of intact, neighboring endothelium. Such a functional importance has previously been demonstrated only in a static system."
As expected, the data for 6-Keto-PGFI, show a significant reduction for ECMs treated with LA. The residual value (0.36 ng/mL) for 6-Keto-PGF,, can be attributed to four possible causes: (1) incomplete inactivation of endothelial cell cyclo-oxygenase; (2) 6-Keto-PGF,, in the thin layer of culture medium present on the ECMs at the time of chamber assembly; (3) PGI, production by monocytes and granulocytes2' during the time blood is in the stirred beaker; and (4) other prostaglandins that cross-react with the antibody used in the RIA. For a blood-free, static system, PGI, production was effectively abolished by incubation of ECMs for 30 minutes with either LA or aspirin. This was true for both stimulated (see Results) and basal ( Table 2 ) production of PGI,. For chamber outflow samples collected over 7.5 minutes, the second cause is known to be ~nimportant.,~ As for the third cause, the values of Table 1 for 6-Keto-PGFI, before and after oral aspirin suggest a contribution that could be as large as 0.20 ng/mL. We conclude, therefore, that the residual value for 6-Keto-PGFI, is due to some combination of leukocyte-derived PGI, and prostaglandins that crossreact with the RIA antibody. Table 1 shows that oral aspirin caused a paradoxic increase in the percent surface area covered by platelets. In view of the fact that mean aggregate thickness actually decreased in five of six experiments, thrombus volume was not significantly increased relative to control. These observations imply that oral aspirin leads to an increase in the adhesion of single platelets at the expense of platelet aggregation, as is suggested by Fig 9 and has been reported to be the case in the Baumgartner device." An explanation for this paradox is that in the presence of Role of oral aspirin.
adherent platelet aggregates not all of the platelet-free injury area is accessible to platelets from flowing blood. This is due to the existence of wakes (protected regions of slow flow) extending downstream from the downstream edges of these aggregates., ' Baumgartner was able to detect an effect of aspirin on platelet deposition on subendothelium exposed to flowing, citrated blood, but not with heparinized blood.25 The presence of an aspirin effect, however, seems to be less dependent on the use of citrate than on the degree of endothelial and/or vessel wall injury (into the vessel media in Baumgartner's case). Thus, an effect of aspirin can be seen in vivo (no anticoagulant) in animal models using more localized i n j~r y . '~,~~ Bovine aortic endothelial cells were used in the present work because of their ability to grow well on cover glasses for up to 24 passages. Human umbilical vein endothelial cells, on the other hand, grow best in the presence of heparin and/or endothelial cell growth factor, substances associated with significant reductions in PGI, production.28 Nevertheless, preliminary experiments with monolayers of primary passage human umbilical vein endothelial cells show platelet adhesion/aggregation confined to the injury area and subject to a similar modulation by LA or oral aspirin.
Anticoagulant.
Use of human umbilical vein endothelial cells.
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APPENDIX
For a parallel-plate geometry, the absolute value of wall shear rate, y, can be shownz9 to be given by:
where Q is flow rate in cm'/sec, w is channel width in cm, and h is channel half-height in cm. For Q, w, and h of 1.67 x lo-, cm'/sec (1.0 cm3/min), 0.44 cm, and 0.0145 cm, respectively, y has a value of 270 sec-'.
